Skip to main content

@WHO: RT @DrTedros: The review will consider data collected so far in the Solidarity and other trials, in particular robust randomised data, to evaluate the potential benefits and harms from the use of hydroxychloroquine. The other arms of the Solidarity trial are continuing. #COVID19

http://twitter.com/WHO
via IFTTT

Comments